Hotline for Health Services for Displaced Lebanese 1787
Hotline for the Patient Admission to Hospitals 01/832700
COVID-19 Vaccine Registration Form covax.moph.gov.lb
MoPH Hotline 1214
Are you a new member? Sign up now
 
Let us help you
Read about the latest topics.

Moph: Prevention Guidance following the Storm Repercussions

 
The Information office of the Ministry of Public Health issued the following statement:

In anticipation of the upcoming storms that will hit Lebanon, and in the light of its awareness-raising tasks, the Ministry of Public Health issued the following guidelines to ensure the safety of the citizens.
  • Follow the safety standards while using heating appliances, in particular at night to prevent any gas leak or fire.
  • Equip your houses with fire extinguishers.
  • Avoid moving between cold and hot areas and drink plenty of fluids to prevent dehydration.
  • People with heart diseases, asthma or obstructive pulmonary are advised not to leave home to avoid exposure to cold air that might cause health problems.
  • Store sufficient quantities of medicines for all the period of the storm.
For more information on the protection from accidents caused by heating appliances, read the following guidelines on children protection.
 
Heating:
  • When using an electric heater, check the electric cables to avoid any electrical fire
  • When using a gas heater, check the gas hose for any gas leak
  • When using  coal – wood – diesel heaters, the following should be considered:
 
  • Don’t allow children to contact or play with the flame to prevent burns, accidents and suffocation
  • Equip your houses with fire extinguishers, fire blanket and  a smoke detector (if possible)
  • Keep the heater far from diesel tanks
  • Ensure flammable items are kept away from the heating appliances (curtains, blankets…)
  • Don’t keep the clothes close to heating appliances to dry them 
Personal prevention tips:
  • Avoid exposing your back and neck to cold air and wear suitable clothes
  • Avoid moving between cold and hot areas
  • Drink plenty of water and fluids to prevent dehydration
  • Turn off your home’s electricity in the event of flooded home 
People with chronic diseases:
  • People with asthma or obstructive pulmonary are advised not to leave home during the storm
  • People with heart diseases are advised to stay home since cold air can cause vessels/ coronary arteries to narrow, which can lead to a pain in the chest
  • Store sufficient quantities of medicines for all the period of the storm. 
Tips for children

Clothing:
  • Dress your infants and children in warm clothes, in particular when going outside. Don’t forget winter accessories such as gloves and hat. Dress babies and young children in one more layer of clothing than an adult would wear in the same conditions.
  • blankets, quilts, pillows can cause Sudden Infant death syndrome 
  • Hypothermia
  • Hypothermia is a drop in body temperature caused by exposure to cold temperatures. It usually occurs when children play outside in extremely cold weather without wearing appropriate clothes or when clothes are wet.
  • Symptoms are shivering, mumbling, very low energy and even loss of consciousness. In such a case, bring the child indoors, remove any wet clothes, wrap with blanket or warm clothes and contact the doctor if need be. 
Frostbite
Frostbite occurs when cold causes extremities to freeze, such as fingers, feet, ears and nose which may become white or blue, or may itch or burn.

In case of frostbite, the child should be brought indoors and his injured parts should be put in warn water. Warm towels can also be applied to nose, ears and lips. Do not to rub the frozen area surfaces. A few minutes later, give the child warm fluids to drink. If numbness persisted more than a couple of minutes, contact your doctor.
 
    ...
    56
    ...
ATC Name B/G Ingredients Dosage Form Price
L04AB02 REMSIMA SC BioTech Infliximab - 120mg/ml 120mg/ml Injectable solution 91,457,321 L.L
L01FA01 RIXATHON BioTech Rituximab - 500mg/50ml 500mg/50ml Injectable concentrate for solution 64,401,569 L.L
L04AB02 REMSIMA SC BioTech Infliximab - 120mg/ml 120mg/ml Injectable solution 52,597,003 L.L
L01FA01 RIXATHON BioTech Rituximab - 500mg/50ml 500mg/50ml Injectable concentrate for solution 111,983,163 L.L
L04AB04 ABRILADA BioTech Adalimumab - 40mg 40mg Injectable solution 40,259,574 L.L
B02BD02 NOVOEIGHT BioTech Turoctocog Alfa - 500IU 500IU Injectable powder for solution+diluent 29,783,973 L.L
L01FA01 RUXIENCE BioTech Rituximab - 500mg/50ml 500mg/50ml Injectable concentrate for solution 59,148,151 L.L
L04AB04 ABRILADA BioTech Adalimumab - 40mg 40mg Injectable solution 40,259,574 L.L
B02BD02 NUWIQ BioTech Coagulation Factor VIII recombinant, human (Simoctogog alfa) - 500IU 500IU Injectable powder for solution+diluent 45,612,427 L.L
L01FA01 TRUXIMA BioTech Rituximab - 500mg/50ml 500mg/50ml Injectable concentrate for solution 69,144,591 L.L
L04AB04 ADALIREL BioTech Adalimumab - 40mg 40mg Injectable solution 15,102,158 L.L
B02BD02 RECOFACT VIII BioTech Moroctocog alfa - 500IU 500IU Injectable powder for solution+diluent 12,049,005 L.L
L01FA01 ZYTUX BioTech Rituximab - 500mg/50ml 500mg/50ml Injectable concentrate for solution 27,724,196 L.L
L04AB04 CINNORA BioTech Adalimumab - 40mg/0.8ml 40mg/0.8ml Injectable solution 14,817,734 L.L
B02BD02 XYNTHA BioTech Moroctocog alfa - 500IU 500IU Injectable lyophilised powder for solution+diluent 23,067,288 L.L
L01FA03 GAZYVA BioTech Obinutuzumab - 1000mg/40ml 1000mg/40ml Injectable concentrate for solution 314,437,416 L.L
L04AB04 HUMIRA BioTech Adalimumab - 40mg/0.4ml 40mg/0.4ml Injectable solution 33,860,031 L.L
B02BD02 ESPEROCT BioTech Turoctocog Alfa pegol (recombinant coagulation factor VIII) - 500IU/Vial 500IU/Vial Injectable powder for solution+diluent 38,126,657 L.L
L01FB01 BESPONSA FOR INJECTION BioTech Inotuzumab Ozogamicin - 0.9mg 0.9mg Injectable powder for suspension 921,176,511 L.L
L04AB04 HYRIMOZ BioTech Adalimumab - 40mg 40mg Injectable solution 27,521,893 L.L
B02BD02 ESPEROCT BioTech Turoctocog Alfa pegol (recombinant coagulation factor VIII) - 1000IU/Vial 1000IU/Vial Injectable powder for solution+diluent 72,849,268 L.L
L01FC01 DARZALEX BioTech Daratumumab - 400mg/20ml 400mg/20ml Injectable concentrate for solution 164,970,376 L.L
L04AB04 HYRIMOZ BioTech Adalimumab - 40mg 40mg Injectable solution 27,521,893 L.L
L01FC01 DARZALEX BioTech Daratumumab - 1800mg 1800mg Injectable solution 494,909,963 L.L
L04AB06 SIMPONI BioTech Golimumab - 50mg/0.5ml 50mg/0.5ml Injectable solution 72,719,241 L.L
L01FD01 ARYOTRUST BioTech Trastuzumab - 440mg 440mg Injectable powder for concentrate for solution + solvent 34,948,930 L.L
L04AB06 SIMPONI BioTech Golimumab - 100mg/1ml 100mg/1ml Injectable solution 72,719,241 L.L
L01FD01 HERCEPTIN BioTech Trastuzumab - 440mg 21mg/ml Injectable concentrated powder for solution+diluent 166,423,476 L.L
L04AC02 SIMULECT BioTech Basiliximab - 20mg 20mg Injectable powder + solvent 131,822,828 L.L
L01FD01 HERCEPTIN BioTech Trastuzumab - 440mg 21mg/ml Injectable concentrated powder for solution+diluent 166,423,476 L.L
    ...
    56
    ...
Sitemap
© Copyrights reserved to Ministry of Public Health 2025